-
Horwitz DA, Gray JD, Zheng SG: The potential of human regulatory T–cells generated ex–vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res 4:241–246, 2002.
-
Zheng SG, Dray JD, Ohtsuka K, Yamagiwa S, Horwitz DA: Generation ex–vivo of TGF–beta producing regulatory T–cells from CD4+CD25–precursors. J Immunol 169:4183–4189, 2002.
-
Horwitz DA, Zheng SG, Gray JD: The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and junction of CD4+ CD25+ and CD8+ regulatory T cell subsets. J Leukoc Biol 74:471–478, 2003.
-
Zheng SG, Koss MN, Quismorio Jr FP, Wang JH, Gray JD, Horwitz DA: CD4+ and CD8+ regulatory T cells generated ex-vivo with IL-2 and TGF-beta suppress a stimulatory graft-verse-host-disease with a lupus-like syndrome. J Immunol 172:1531-1539, 2004.
-
Zheng SG: The role of IL-2, TGF-beta and IL-10 in the generation and renewal of regulatory T cells: interactions between CD4+CD25+ cells and Naïve CD4+CD25+ cells. J Immunol 172:5213-5221, 2004.
-
Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S: Regulatory T cells generated ex-vivo as an approach of the therapy of autoimmune disease. Seminar Immunol 16:135-143, 2004.
-
Zheng SG, Meng L, Wang JH, Watanabe M, Barr ML, Cramer DV, Gray JD, Horwitz DA: Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. Int Immunol 18:279-289, 2006.
-
Zheng SG, Wang JH, Kim S, Stohl W, Gray JD, Horwitz DA: TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol, 176:3321-3329, 2006.
-
Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. 2007 178:2018-2027
-
Xue Y, Zou HJ and Zheng SG*. Role of Th17 cells in the autoimmunity. Chin J Micro Immunol, 2007, 27:868-870
-
Ma JL, Tao XJ, Cai L and Zheng SG*. Characterization of CD4+CD25+Foxp3+ cells in active SLE patients. Chin J Rheumatol, 2007, 11: 654-657
-
Tao XJ, Ma JL, Yu JL, Zhang YH, Wang JH and Zheng SG*. Neutralization of IL-4 and IFN-γ facilitates the development of TGF-β-induced CD4+CD25+Foxp3+ regulatory T cells. Inter J Biomed Sci. 2008, 4:100-106
-
Yu JN, Ma JL, Wang JH , Tao XJ, Li XP, Zou HJ and Zheng SG*. FOXP3, is still a specific marker for human regulatory T cells? Chin J Allergy Clin Immunol, 2008, 2:5-10
-
Xue Y, Zhang J, Chen YM, Guan M, Zheng SG* and Zou HJ. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Scan J Rheumatol, 2008, 37: 183-187
-
Horwitz DA, Zheng SG, Wang JH and Gray JD. The real role of TGF-β in Treg cells physiology. Eur J Immunol, 2008, 38: 912-915
-
Zheng SG*, Wang JH, Horwitz DA. Contrasting effect of IL-6 on the suppressive activity of natural and induced regulatory T cells. J Immunol, Cutting-edge, 2008, 180: 7112-7116
-
Zheng SG*. The critical role of TGF-β1 in the development of induced Foxp3+ regulatory T cells. Int J Clin Exp Med, 2008, 1: 192-202
-
Liu ZM, Fan HM, Li LY, Zheng SG*. Experimental Studies on the Differentiation of Fibroblasts into Myoblasts induced by MyoD Genes in vitro. Int J Biomed Sci 2008; 4: 14-19
-
Zhao SS, Li XM, Li XP, Zhai ZM, Chen Z, Ma Y, Zhang H, Zheng SG. Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus. Chin J Med. 2008, 88: 453-456
-
Horwitz DA, Zheng SG. Gray JD. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 2008, 29: 429-435